Your session is about to expire
← Back to Search
Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy
Phase 3
Waitlist Available
Led By Kuwong B Mwamukonda, MD
Research Sponsored by Brooke Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post surgery
Awards & highlights
Pivotal Trial
Approved for 5 Other Conditions
All Individual Drugs Already Approved
Summary
This trial will compare the effectiveness of two drugs in helping men regain erectile function after surgery for prostate cancer.
Eligible Conditions
- Erectile Dysfunction
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months post surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Erectile function
Secondary study objectives
Penile length
Awards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Trial Design
3Treatment groups
Active Control
Placebo Group
Group I: Sildenafil 25mg Oral TabletActive Control1 Intervention
25mg sildenafil citrate twice daily
Group II: PentoxifyllineActive Control1 Intervention
400mg pentoxifylline twice daily
Group III: PlaceboPlacebo Group1 Intervention
placebo twice daily
Find a Location
Who is running the clinical trial?
Walter Reed National Military Medical CenterFED
141 Previous Clinical Trials
32,973 Total Patients Enrolled
Brooke Army Medical CenterLead Sponsor
129 Previous Clinical Trials
27,457 Total Patients Enrolled
Kuwong B Mwamukonda, MDPrincipal Investigator - Brooke Army Medical Center
Brooke Army Medical Center